Natural killer (NK) cells play a crucial role in immune surveillance against a variety of microbial pathogens, viruses, and cancerous cells. Infusions of NK cells are a promising tool for cancer immunotherapy. Therefore, the development of clinically applicable methods to produce large numbers of highly potent NK cells is critical for cancer cell therapy.